News Stories

30 May 2007
Ovid Partners With Springer

Ovid Technologies announced at this year’s Medical Library Association Annual (MLA) Conference that it has entered into a partnership agreement with Springer Science+Business Media to offer more than 800 electronic medical and health sciences books from Springer on its industry-leading e-books platform, Books@Ovid.

“Springer is widely and rightly recognized the world over for its extensive publishing lists of books and journals in all medicine and health science specialties,” said Scott MacFarland, Ovid’s Vice President for Content Management. “Adding content from a publisher of this calibre greatly enhances the value of our Books@Ovid platform, expanding e-resource choice for our customers and end users in research, education, and clinical practice. This agreement underscores our position as the primary destination for comprehensive electronic medical resources.”

As part of the agreement, Ovid will offer more than 800 medical and health sciences titles to medical organizations globally, including hospitals and hospital consortia, medical schools, and medical departments or entities within a higher education institution, government organization, or corporation. The books will be available via an annual renewable subscription or as a one-time purchase, which provides the institution the right to own the book in perpetuity. Key titles coming to Books@Ovid include AJCC Cancer Staging Atlas, Medical Informatics, and Minimally Invasive Spine Surgery, widely considered must-have, “core” resources in their respective disciplines. Content is expected to become available on the Books@Ovid platform beginning in the third quarter.

“The decision to partner with Ovid was an easy one. The Ovid brand is very strong among hospitals and medical institutions, two markets in which we’re eager to increase our global presence,” said Dr. Kim Zwollo, Global Director Special Licensing & Rights for Springer. “This new initiative will go a long way towards bringing our product lines to new audiences all over the world.”

www.ovid.com

www.wolterskluwer.com

Discuss this article in the forum